<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Drug Brand Names Y.&amp; R. Advertising</title>
    <meta content="MB000617" name="slug"/>
    <meta content="30" name="publication_day_of_month"/>
    <meta content="6" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Friday" name="publication_day_of_week"/>
    <meta content="Business/Financial Desk" name="dsk"/>
    <meta content="5" name="print_page_number"/>
    <meta content="C" name="print_section"/>
    <meta content="2" name="print_column"/>
    <meta content="Health; Business" name="online_sections"/>
    <docdata>
      <doc-id id-string="1211458"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <series series.name="THE MEDIA BUSINESS: ADVERTISING -- ADDENDA"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="indexing_service" type="descriptor">Advertising</classifier>
        <classifier class="indexing_service" type="descriptor">Dieting</classifier>
        <classifier class="indexing_service" type="descriptor">Xenical (Drug)</classifier>
        <org class="indexing_service">Hoffmann-La Roche Inc</org>
        <org class="indexing_service">Young &amp; Rubicam Inc</org>
        <person class="indexing_service">Elliott, Stuart</person>
        <object.title class="indexing_service">Advertising (Times Column)</object.title>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business/Columns/Addenda</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Business/Media and Advertising</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/U.S./South</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Diet</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Health/Diseases, Conditions, and Health Topics/Dieting</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Pharmaceutical, Biotechnology and Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Classifieds/Job Market/Job Categories/Marketing, Advertising and PR</classifier>
        <classifier class="online_producer" type="general_descriptor">Dieting</classifier>
        <classifier class="online_producer" type="general_descriptor">Drugs (Pharmaceuticals)</classifier>
        <classifier class="online_producer" type="general_descriptor">Advertising and Marketing</classifier>
        <classifier class="online_producer" type="general_descriptor">Weight</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000630T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=940DE7DE1739F933A05755C0A9669C8B63" item-length="131" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Drug Brand Names Y.&amp; R. Advertising</hl1>
      </hedline>
      <byline class="print_byline">By STUART ELLIOT</byline>
      <abstract>
        <p>Hoffmann-La Roche Inc, part of Roche Holding, names Young &amp; Rubicam Advertising to handle account for Xenical weight-loss drug; billings estimated at $80 million (Advertising column) (S)</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>Hoffman-La Roche Inc., part of Roche Holding, yesterday named Young &amp; Rubicam Advertising in New York to handle the account for its Xenical weight-loss drug. Billings were estimated at $80 million.</p>
        <p>The decision came after a 10-week review that had been narrowed to Y.&amp; R. Advertising and two other finalists in New York: Jordan McGrath Case &amp; Partners/Euro RSCG, part of the Euro RSCG Worldwide unit of Havas Advertising, and Ogilvy &amp; Mather Worldwide, part of the WPP Group.</p>
      </block>
      <block class="full_text">
        <p>Hoffman-La Roche Inc., part of Roche Holding, yesterday named Young &amp; Rubicam Advertising in New York to handle the account for its Xenical weight-loss drug. Billings were estimated at $80 million.</p>
        <p>The decision came after a 10-week review that had been narrowed to Y.&amp; R. Advertising and two other finalists in New York: Jordan McGrath Case &amp; Partners/Euro RSCG, part of the Euro RSCG Worldwide unit of Havas Advertising, and Ogilvy &amp; Mather Worldwide, part of the WPP Group.</p>
        <p>The Xenical account had been handled by divisions of the Lowe Group unit of the Interpublic Group of Companies, which parted ways with Hoffman-La Roche in April. They were Lowe Consumer Healthcare, for campaigns aimed at consumers, and Lowe McAdams Healthcare, for campaigns aimed at doctors.</p>
        <p>THE MEDIA BUSINESS: ADVERTISING -- ADDENDA</p>
      </block>
    </body.content>
  </body>
</nitf>
